Literature DB >> 22751490

Therapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy?

C L H Bockting, R J Mocking, A Lok, M W J Koeter, A H Schene.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22751490     DOI： 10.1038/mp.2012.92

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  14 in total

1.  Catehol-o-methyltransferase gene Val158met polymorphism as a potential predictor of response to computer-assisted delivery of cognitive-behavioral therapy among cocaine-dependent individuals: Preliminary findings from a randomized controlled trial.

Authors:  Kathleen M Carroll; Aryeh Herman; Elise E DeVito; Tami L Frankforter; Marc N Potenza; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2015-05-01

Review 2.  'As above, so below' examining the interplay between emotion and the immune system.

Authors:  Samuel Brod; Lorenza Rattazzi; Giuseppa Piras; Fulvio D'Acquisto
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

3.  5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial.

Authors:  Andrew T Gloster; Alexander L Gerlach; Alfons Hamm; Michael Höfler; Georg W Alpers; Tilo Kircher; Andreas Ströhle; Thomas Lang; Hans-Ulrich Wittchen; Jürgen Deckert; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-15       Impact factor: 5.270

Review 4.  Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.

Authors:  R J T Mocking; J Assies; H G Ruhé; A H Schene
Journal:  J Inherit Metab Dis       Date:  2018-03-09       Impact factor: 4.982

5.  Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia.

Authors:  Ulrike Lueken; Benjamin Straube; Hans-Ulrich Wittchen; Carsten Konrad; Andreas Ströhle; André Wittmann; Bettina Pfleiderer; Volker Arolt; Tilo Kircher; Jürgen Deckert; Andreas Reif
Journal:  J Neural Transm (Vienna)       Date:  2014-09-16       Impact factor: 3.575

6.  Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences?

Authors:  J M Bakker; R Lieverse; C Menne-Lothmann; W Viechtbauer; E Pishva; G Kenis; N Geschwind; F Peeters; J van Os; M Wichers
Journal:  Transl Psychiatry       Date:  2014-04-22       Impact factor: 6.222

7.  Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disorders.

Authors:  Kathryn J Lester; Susanna Roberts; Robert Keers; Jonathan R I Coleman; Gerome Breen; Chloe C Y Wong; Xiaohui Xu; Kristian Arendt; Judith Blatter-Meunier; Susan Bögels; Peter Cooper; Cathy Creswell; Einar R Heiervang; Chantal Herren; Sanne M Hogendoorn; Jennifer L Hudson; Karen Krause; Heidi J Lyneham; Anna McKinnon; Talia Morris; Maaike H Nauta; Ronald M Rapee; Yasmin Rey; Silvia Schneider; Sophie C Schneider; Wendy K Silverman; Patrick Smith; Mikael Thastum; Kerstin Thirlwall; Polly Waite; Gro Janne Wergeland; Thalia C Eley
Journal:  Br J Psychiatry       Date:  2015-08-20       Impact factor: 9.319

8.  Functional gene polymorphisms in the serotonin system and traumatic life events modulate the neural basis of fear acquisition and extinction.

Authors:  Andrea Hermann; Yvonne Küpper; Anja Schmitz; Bertram Walter; Dieter Vaitl; Jürgen Hennig; Rudolf Stark; Katharina Tabbert
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

9.  Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders.

Authors:  Kathryn J Lester; Thalia C Eley
Journal:  Biol Mood Anxiety Disord       Date:  2013-02-07

10.  Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder.

Authors:  Evelyn Andersson; Christian Rück; Catharina Lavebratt; Erik Hedman; Martin Schalling; Nils Lindefors; Elias Eriksson; Per Carlbring; Gerhard Andersson; Tomas Furmark
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.